Form 8-K · Current report
Qualcomm 8-K, filed Jul 31, 2026
- Filed
- CIK
- 0000804328
- Accession no.
- 0001104659-26-089234
Summary
Qualcomm filed a prospectus supplement covering the resale of 17,826,566 shares of its common stock that it issued as consideration for its acquisition of Modular Inc under a June 21, 2026 definitive agreement, with the shares issued in a private placement. The supplement was filed under a July 28, 2026 registration rights agreement between Qualcomm and Shareholder Representative Services LLC, acting for the holders.
Key points
- Qualcomm's June 21, 2026 definitive agreement to acquire Modular Inc was previously announced.
- Qualcomm issued 17,826,566 shares of common stock (par value $0.0001) as consideration for the Modular acquisition in a private placement relying on Section 4(a)(2) and Rule 506 of Regulation D.
- The registration rights agreement is dated July 28, 2026, between Qualcomm and Shareholder Representative Services LLC as representative of the holders.
- A legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP on the shares was filed as an exhibit.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. On July 31, 2026, QUALCOMM Incorporated (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s Registration Statement on Form S-3ASR filed with the SEC on November 6, 2024 (File No. 333-283035) (the “Registration Statement”), covering the resale by the selling stockholders of an aggregate of 17,826,566 shares of Company common stock, par value $0.0001 per share (the “Shares”). As previously announced, on June 21, 2026, the Company entered into a definitive agreement to acquire Modular Inc (“Modular”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.